These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Effect of TS 160 in the treatment of chronic gingivitis and periodontosis]. KOSTLAN J, SOYKA O, PRASIL K. Cas Lek Cesk; 1952 May 30; 91(22):649-51. PubMed ID: 14390246 [No Abstract] [Full Text] [Related]
49. Therapeutic targets in the nitrogen mustard sensitivity of B-cell chronic lymphocyte leukemia (B-CLL). Kannan S. Med Hypotheses; 2006 Jan 02; 67(4):998. PubMed ID: 16757124 [No Abstract] [Full Text] [Related]
51. [Our experience in the use of some nitrogen mustard derivatives]. CUCINOTTA U. G Ital Chemioter; 1956 Jan 02; 3(3-4):585-7. PubMed ID: 13462214 [No Abstract] [Full Text] [Related]
52. [Nitrogen mustard therapy of acromegaly]. QUINTANILLA ULLA J. Medicamenta (Madr); 1954 Aug 02; 2(2):105-12. PubMed ID: 13234975 [No Abstract] [Full Text] [Related]
60. [Range of indication for nitrogen mustard oxide in the therapy of malignant tumors]. BECKER T. Strahlentherapie; 1957 Jun 03; 15(Sonderbd. 37):279-80. PubMed ID: 13495778 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]